Factors affecting high-sensitivity cardiac troponin T elevation in Japanese metabolic syndrome patients

Takashi Hitsumoto1, Kohji Shirai2

  • 1Hitsumoto Medical Clinic, Yamaguchi, Japan.

Insights

In Japanese metabolic syndrome patients, elevated high-sensitivity cardiac troponin T (hs-cTnT) is linked to oxidative stress and arterial dysfunction, not metabolic parameters. Age also influences hs-cTnT levels.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Biomarkers

Background:

  • High-sensitivity cardiac troponin T (hs-cTnT) is a key biomarker for heart failure and cardiovascular events.
  • The clinical significance of hs-cTnT in metabolic syndrome remains largely unexplored.
  • Understanding hs-cTnT in metabolic syndrome is crucial for risk stratification.

Purpose of the Study:

  • To investigate factors associated with elevated hs-cTnT in Japanese patients with metabolic syndrome.
  • To explore the relationship between hs-cTnT and diagnostic parameters of metabolic syndrome.
  • To identify independent predictors of hs-cTnT elevation in this population.

Main Methods:

  • A cohort of 258 middle-aged Japanese males with metabolic syndrome and no prior cardiovascular events was studied.
  • hs-cTnT levels were measured and correlated with various clinical parameters, including metabolic syndrome diagnostic criteria.
  • Multiple regression analysis was employed to identify independent predictors of hs-cTnT.

Main Results:

  • No significant correlation was found between hs-cTnT and standard metabolic syndrome diagnostic parameters.
  • hs-cTnT showed significant positive correlations with age, brain natriuretic peptide, reactive oxygen metabolites (oxidative stress marker), and cardio-ankle vascular index (arterial function marker).
  • Multiple regression confirmed age, oxidative stress, and arterial function as independent factors associated with hs-cTnT levels.

Conclusions:

  • In Japanese metabolic syndrome patients, elevated hs-cTnT is associated with in vivo oxidative stress and arterial dysfunction.
  • These findings suggest that hs-cTnT may reflect subclinical cardiovascular damage related to oxidative stress and vascular abnormalities in metabolic syndrome.
  • The study highlights the importance of assessing oxidative stress and arterial function in metabolic syndrome patients with elevated hs-cTnT.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
481
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
783
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
466
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793